Cardiology Letters 2018, 27(3):148-152
Betablockers and systolic heart failure
- 1 I. interná klinika LFUK a UN Bratislava
- 2 Ústav farmakológie a klinickej farmakológie LF UK Bratislava, Slovenská republika
Published: March 1, 2018 Show citation
References
- Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J 1991;121:1244-1263.
Go to original source... - Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 2013;113:739-753. Go to original source...
- Lenzen MJ, S Reimer, WJM Boersma, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the Euro Heart Failure Survey. Eur Heart J 2004;25:1214-1220. Go to original source...
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the TASK Force for the diagnosis and treatment of acute and chronic heart failure of the ESC. Eur J Heart Fail 2016;18:891-975. Go to original source...
- Murín J. Heart failure Congress, Vienna, 26-29 May 2018 - osobné zdelenie
- Kenchaiah S, Narula J, Vasan RS. Risk factors for heart failure. Med Clin North Am 2004;88:1145-1172. Go to original source...
- Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure JAMA 1996;275:1557-1562. Go to original source...
- Mann DL. The evoluation of modern theory and therapy for heart failure. Prog Ped Cardiol 2014;37:9-18. Go to original source...
- Vítovec J, Špinar J, Špinarová L. Heart failure and inhibition of renin-angiotensin-aldosterone system. Cor et Vasa 2018;60:e263 - e273. Go to original source...
- The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435 Go to original source...
- Konstam MA, Neaton JD, Dickstein K, et al for the HEAAL investigators. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study). Lancet 2009;374:1840-1848. Go to original source...
- Rundqvist B, Elam M, Bergmann, et al. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997;95:169-175. Go to original source...
- Pernický M, Murín J. Pacienti v pohotovostnej službe na internej klinike. Cardiology sk 2010;19:287-292.
- Ponikowski P, Anker SD, Al-Habib KF, et al. Heart failure: preventing disease and death world wide. ESC Heart failure 2014;1:4-25. Go to original source...
- MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Lancet 1999;353:2001-2007. Go to original source...
- Cibis-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II: a randomised trial. Lancet 1999;353:9-13. Go to original source...
- Packer M, Fowler MB, Roecker EB, et al. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Circulation 2002;106:2194-2199. Go to original source...
- Flather MD, Shibata MC, Coats AJ, et al. (SENIORS investigators). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure. Eur Heart J 2005;26:215-225. Go to original source...
- McMurray JVV, Cohen-Solal A, Dietz R, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 2005;7:710-772. Go to original source...
- Sze S, Pellicori P, Kamzi S, et al. Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. Intern J Cardiol 2018;269:104-112. Go to original source...
- Düngen HD, Apostolovic S, Inkrot S, et al. CIBIS-ELD Investigators and Project Multicentre Trials in the Competence Network Heart Failure. Titration to target dose of bisoprolol vs carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail 2011;13:670-680. Go to original source...
- Wieselgren I, Lundborg P, Sandberg A, et al. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release CR/ZOK) 50 mg in young subjects. J Clin Pharmacol 1990;30:S28-S32. Go to original source...
- Bozkurt B. What is new in heart failure management in 2017? Update on ACC/AHA heart failure guidelines. Curr Cardiology Reports 2018;20:1-9. Go to original source...